Pioglitazone: A Promising Therapeutic Tool in Sodium Taurocholate-Induced Severe Acute Pancreatitis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Digestive Diseases and Sciences

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10620-010-1393-0PMID 20824499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.

  2009cited by this paper
• Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis.

  2007cited by this paper
• Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis.

  2006cited by this paper
• PPARgamma phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation.

  2006cited by this paper
• PPARγ phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation

  2006cited by this paper
• Anti-inflammatory effects of PPAR-γ agonists directly correlate with PPAR-γ expression during acute pancreatitis

  2006cited by this paper
• Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, protects pancreas against acute cerulein-induced pancreatitis.

  2005cited by this paper
• Different profile of cytokine synthesis according to the severity of acute pancreatitis.

  2005cited by this paper
• Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein

  2004cited by this paper
• The 15-Deoxy-δ12,14-Prostaglandin J2 Inhibits the Inflammatory Response in Primary Rat Astrocytes via Down-Regulating Multiple Steps in Phosphatidylinositol 3-Kinase-Akt-NF-κB-p300 Pathway Independent of Peroxisome Proliferator-Activated Receptor γ1

  2004cited by this paper
• Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.

  2004cited by this paper
• The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.

  2004cited by this paper
• Comparative study on acute pancreatitis management

  2004cited by this paper
• Peroxisome Proliferator Activator Receptor-γ Ligands, 15-Deoxy-Δ12,14-Prostaglandin J2 and Ciglitazone, Reduce Systemic Inflammation in Polymicrobial Sepsis by Modulation of Signal Transduction Pathways 1

  2003cited by this paper
• A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model.

  2003cited by this paper
• Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.

  2003cited by this paper
• The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis.

  2003cited by this paper
• The PPAR&ggr; Ligand, 15d-PGJ2, Attenuates the Severity of Cerulein-Induced Acute Pancreatitis

  2003cited by this paper
• Prevention of Ethanol-Induced Liver Injury in Rats by an Agonist of Peroxisome Proliferator-Activated Receptor-γ, Pioglitazone

  2003cited by this paper
• Peroxisome Proliferator–Activated Receptor- γ Regulates Airway Epithelial Cell Activation

  2001cited by this paper
• Hepatic over-expression of peroxisome proliferator activated receptor γ2 in the ob/ob mouse model of non‐insulin dependent diabetes mellitus

  2001cited by this paper
• Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation.

  2001cited by this paper
• Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of the Inducible Nitric Oxide Synthase Gene

  2000cited by this paper
• Down regulation of peroxisome proliferator-activated receptorγ expression by inflammatory cytokines and its reversal by thiazolidinediones

  1999cited by this paper
• Medical significance of peroxisome proliferator-activated receptors.

  1999cited by this paper
• The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

  1998cited by this paper
• Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice

  1998cited by this paper
• PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

  1998cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Decreased Expression of Murine PPARγ in Adipose Tissue during Endotoxemia.

  1997cited by this paper
• Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis.

  1997cited by this paper
• Interleukin 10 reduces the severity of acute pancreatitis in rats.

  1997cited by this paper
• Decreased expression of murine PPARgamma in adipose tissue during endotoxemia.

  1997cited by this paper
• Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis

  1996cited by this paper
• Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat.

  1996cited by this paper
• Circulating endotoxin, tumour necrosis factor-alpha, and their natural antagonists in the pathophysiology of acute pancreatitis.

  1996cited by this paper
• A better model of acute pancreatitis for evaluating therapy.

  1992cited by this paper
• the of in Peroxisome proliferator-activated receptor γ agonist reduces the severity of post-ERCP pancreatitis in rats

  year unknowncited by this paper

• Induction of hyperlipidemic pancreatitis by different fatty acids: A narrative review

  2025cites this paper
• Farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (TGR5) signaling pathways improved the hepatic lipid metabolism in hybrid grouper

  2022cites this paper
• Farnesoid X receptor regulates PI3K/AKT/mTOR signaling pathway, lipid metabolism, and immune response in hybrid grouper

  2022cites this paper
• Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry

  2022cites this paper
• Phosphoinositide 3‑kinase/protein kinase B regulates inflammation severity via signaling of Toll‑like receptor 4 in severe acute pancreatitis.

  2018cites this paper
• Translational Insights Into Peroxisome Proliferator-Activated Receptors in Experimental Acute Pancreatitis

  2016cites this paper
• Pharmacokinetics and clinical evaluation of the alogliptin plus pioglitazone combination for type 2 diabetes

  2015cites this paper
• Unsaturated but not saturated fatty acids induce transcriptional regulation of CCL2 in pancreatic acini. A potential role in acute pancreatitis.

  2015cites this paper
• Cross-talk between TLR4 and PPARγ pathways in the arachidonic acid-induced inflammatory response in pancreatic acini.

  2015cites this paper
• A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position

  2014cites this paper
• Pancreatitis-Associated Ascitic Fluid Induces Proinflammatory Cytokine Expression in THP-1 Cells by Inhibiting Anti-inflammatory Signaling

  2013cites this paper
• Regulatory Roles of the PI3K/Akt Signaling Pathway in Rats with Severe Acute Pancreatitis

  2013cites this paper
• The protective effects of taurine on experimental acute pancreatitis in a rat model

  2013cites this paper
• Effects of Peroxisome Proliferator-Activated Receptor-γ Activation on Apoptosis in Rats with Acute Pancreatitis

  2013cites this paper
• ASSESSMANT OF EFFICACY OF ORAL ANTI-DIABETIC AGENTS IN TREATMENT OF PANCREATOGENIC DIABETES MELLITUS

  2012influential citation
• Biology and therapeutic applications of peroxisome proliferator- activated receptors.

  2012cites this paper